المؤلفون: Kitagawa, Y, Matsuda, S, Gotoda, T, Kato, K, Wijnhoven, B, Lordick, F, Bhandari, P, Kawakubo, H, Kodera, Y, Terashima, M, Muro, K, Takeuchi, H, Mansfield, PF, Kurokawa, Y, So, J, Monig, SP, Shitara, K, Rha, SY, Janjigian, Y, Takahari, D, Chau, I, Sharma, P, Ji, JF, de Manzoni, G, Nilsson, M, Kassab, P, Hofstetter, WL, Smyth, EC, Lorenzen, S, Doki, Y, Law, S, Oh, D, Ho, KY, Koike, T, Shen, L, van Hillegersberg, R, Kawakami, H, Xu, RH, Wainberg, Z, Yahagi, N, Lee, YY, Singh, R, Ryu, MH, Ishihara, R, Xiao, ZL, Kusano, C, Grabsch, HI, Hara, H, Mukaisho, KI, Makino, T, Kanda, M, Booka, E, Suzuki, S, Hatta, W, Kato, M, Maekawa, A, Kawazoe, A, Yamamoto, S, Nakayama, I, Narita, Y, Yang, HK, Yoshida, M, Sano, T

المصدر: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 27(3):401-425

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:155214589Test

المؤلفون: Takei, S., Kawazoe, A., Jubashi, A., Komatsu, M., Sato, K., Mishima, S., Kotani, D., Yura, M., Sakamoto, N., Sakashita, S., Kuwata, T., Kojima, T., Fujita, T., Kinoshita, T., Shitara, K.

المساهمون: Meso Scale Diagnostics, Roche

المصدر: ESMO Gastrointestinal Oncology ; volume 4, page 100050 ; ISSN 2949-8198

الإتاحة: https://doi.org/10.1016/j.esmogo.2024.100050Test
https://api.elsevier.com/content/article/PII:S2949819824000116?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2949819824000116?httpAccept=text/plainTest

المؤلفون: Mazzoli, G., Nichetti, F., Shitara, K., Cohen, R., Lonardi, S., Cremolini, C., Elez, M.E., Chao, J., Fakih, M., Klempner, S.J., Jayachandran, P., Maron, S., Cowzer, D., Fornaro, L., Salvatore, L., Zhu, V., Aoki, Y., Cerantola, R., Bergamo, F., Salati, M., Ambrosini, M., Sabella, G., Randon, G., Overman, M.J., André, T., Pietrantonio, F.

المساهمون: Conquer Cancer Foundation, AstraZeneca

المصدر: ESMO Gastrointestinal Oncology ; volume 3, page 100037 ; ISSN 2949-8198

الإتاحة: https://doi.org/10.1016/j.esmogo.2023.100037Test
https://api.elsevier.com/content/article/PII:S2949819823000523?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2949819823000523?httpAccept=text/plainTest

المؤلفون: Shitara, K., Fleitas, T., Kawakami, H., Curigliano, G., Narita, Y., Wang, F., Wardhani, S.O., Basade, M., Rha, S.Y., Wan Zamaniah, W.I., Sacdalan, D.L., Ng, M., Yeh, K.H., Sunpaweravong, P., Sirachainan, E., Chen, M.-H., Yong, W.P., Peneyra, J.L., Ibtisam, M.N., Lee, K.-W., Krishna, V., Pribadi, R.R., Li, J., Lui, A., Yoshino, T., Baba, E., Nakayama, I., Pentheroudakis, G., Shoji, H., Cervantes, A., Ishioka, C., Smyth, E.

المساهمون: Japanese Society of Medical Oncology

المصدر: ESMO Open ; volume 9, issue 2, page 102226 ; ISSN 2059-7029

الإتاحة: https://doi.org/10.1016/j.esmoop.2023.102226Test
https://api.elsevier.com/content/article/PII:S2059702923014679?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702923014679?httpAccept=text/plainTest

المؤلفون: Kubota Y, Aoki Y, Kawazoe A, Shitara K

المصدر: Cancer Management and Research, Vol Volume 14, Pp 3083-3094 (2022)

مصطلحات موضوعية: immune checkpoint inhibitors, chemotherapy, programmed cell death-1, human epidermal growth factor receptor 2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/role-of-nivolumab-in-the-management-of-first-line-unresectable-advance-peer-reviewed-fulltext-article-CMARTest; https://doaj.org/toc/1179-1322Test

الوصول الحر: https://doaj.org/article/377927e4c6fa4fdf97a6609426c0665bTest

المؤلفون: Lam, L.L., Pavlakis, N., Shitara, K., Sjoquist, K.M., Martin, A.J., Yip, S., Kang, Y.K., Bang, Y.J., Chen, L.T., Moehler, M., Bekaii-Saab, T., Alcindor, T., O’Callaghan, C.J., Tebbutt, N.C., Hague, W., Chan, H., Rha, S.Y., Lee, K.W., Gebski, V., Jaworski, A.

المصدر: http://dx.doi.org/10.1186/s12885-023-10642-7Test.

مصطلحات موضوعية: Advanced gastro-oesophageal cancer, Clinical trial, Nivolumab, Regorafenib, Tyrosine kinase inhibitor, Adult, Humans, Pyridines, Stomach Neoplasms, Esophageal Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Double-Blind Method, Randomized Controlled Trials as Topic

وصف الملف: application/pdf

العلاقة: NHMRC; BMC Cancer, 2023; 23(1); https://hdl.handle.net/2440/138674Test; Price, T. [0000-0002-3922-2693]

الإتاحة: https://doi.org/10.1186/s12885-023-10642-7Test
https://hdl.handle.net/2440/138674Test

المؤلفون: Takeda, Y., Misumi, T., Bando, H., Suzuki, M., Wakabayashi, M., Oki, E., Yamazaki, K., Kakeji, Y., Shitara, K., Terashima, M., Raeisi, M., Maehara, Y., Ohtsu, A., Andre, T., de Gramont, A., Shi, Q., Yoshino, T.

المصدر: ESMO Gastrointestinal Oncology ; volume 2, page 100007 ; ISSN 2949-8198

الإتاحة: https://doi.org/10.1016/j.esmogo.2023.08.006Test
https://api.elsevier.com/content/article/PII:S2949819823000080?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2949819823000080?httpAccept=text/plainTest

المؤلفون: Imai, M., Nakamura, Y., Denda, T., Komatsu, Y., Yuki, S., Nishina, T., Hamamoto, Y., Hara, H., Esaki, T., Kawakami, H., Kato, K., Satoh, T., Okano, N., Sunakawa, Y., Taniguchi, H., Yamaguchi, K., Yamada, T., Miki, I., Wakabayashi, M., Kuwata, T., Shitara, K., Yoshino, T.

المساهمون: Merck Sharp and Dohme

المصدر: ESMO Gastrointestinal Oncology ; volume 2, page 100008 ; ISSN 2949-8198

الإتاحة: https://doi.org/10.1016/j.esmogo.2023.08.007Test
https://api.elsevier.com/content/article/PII:S2949819823000079?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2949819823000079?httpAccept=text/plainTest

المؤلفون: Kubota, Y., Kawazoe, A., Mishima, S., Nakamura, Y., Kotani, D., Kuboki, Y., Bando, H., Kojima, T., Doi, T., Yoshino, T., Kuwata, T., Shitara, K.

المساهمون: Astellas Pharma

المصدر: ESMO Open ; volume 8, issue 1, page 100762 ; ISSN 2059-7029

الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100762Test
https://api.elsevier.com/content/article/PII:S2059702922003969?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702922003969?httpAccept=text/plainTest

المؤلفون: Fuca G., Cohen R., Lonardi S., Shitara K., Elez M. E., Fakih M., Chao J., Klempner S. J., Emmett M., Jayachandran P., Bergamo F., Garcia M. D., Mazzoli G., Provenzano L., Colle R., Svrcek M., Ambrosini M., Randon G., Shah A. T., Salati M., Fenocchio E., Salvatore L., Chida K., Kawazoe A., Conca V., Curigliano G., Corti F., Cremolini C., Overman M., Andre T., Pietrantonio F.

المساهمون: Fuca, G., Cohen, R., Lonardi, S., Shitara, K., Elez, M. E., Fakih, M., Chao, J., Klempner, S. J., Emmett, M., Jayachandran, P., Bergamo, F., Garcia, M. D., Mazzoli, G., Provenzano, L., Colle, R., Svrcek, M., Ambrosini, M., Randon, G., Shah, A. T., Salati, M., Fenocchio, E., Salvatore, L., Chida, K., Kawazoe, A., Conca, V., Curigliano, G., Corti, F., Cremolini, C., Overman, M., Andre, T., Pietrantonio, F.

مصطلحات موضوعية: gastrointestinal neoplasm, immunotherapy, translational medical research, tumor biomarkers

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35110358; info:eu-repo/semantics/altIdentifier/wos/WOS:000758164800002; volume:10; issue:2; numberofpages:13; journal:JOURNAL FOR IMMUNOTHERAPY OF CANCER; https://hdl.handle.net/11568/1132688Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85124058744; https://jitc.bmj.com/content/10/2/e004001Test

الإتاحة: https://doi.org/10.1136/jitc-2021-004001Test
https://hdl.handle.net/11568/1132688Test
https://jitc.bmj.com/content/10/2/e004001Test